GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Assura PLC (LSE:AGR) » Definitions » EV-to-EBITDA

Assura (LSE:AGR) EV-to-EBITDA : -17.27 (As of Apr. 28, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Assura EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Assura's enterprise value is £2,433.3 Mil. Assura's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was £-140.9 Mil. Therefore, Assura's EV-to-EBITDA for today is -17.27.

The historical rank and industry rank for Assura's EV-to-EBITDA or its related term are showing as below:

LSE:AGR' s EV-to-EBITDA Range Over the Past 10 Years
Min: -28.83   Med: 16.88   Max: 27.07
Current: -17.27

During the past 13 years, the highest EV-to-EBITDA of Assura was 27.07. The lowest was -28.83. And the median was 16.88.

LSE:AGR's EV-to-EBITDA is ranked worse than
100% of 603 companies
in the REITs industry
Industry Median: 15.25 vs LSE:AGR: -17.27

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-28), Assura's stock price is £0.4144. Assura's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.056. Therefore, Assura's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Assura EV-to-EBITDA Historical Data

The historical data trend for Assura's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assura EV-to-EBITDA Chart

Assura Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.43 27.45 21.41 16.34 -27.94

Assura Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 16.34 - -27.94 -

Competitive Comparison of Assura's EV-to-EBITDA

For the REIT - Healthcare Facilities subindustry, Assura's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Assura's EV-to-EBITDA Distribution in the REITs Industry

For the REITs industry and Real Estate sector, Assura's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Assura's EV-to-EBITDA falls into.



Assura EV-to-EBITDA Calculation

Assura's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2433.330/-140.9
=-17.27

Assura's current Enterprise Value is £2,433.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Assura's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was £-140.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Assura  (LSE:AGR) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Assura's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.4144/-0.056
=At Loss

Assura's share price for today is £0.4144.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Assura's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.056.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Assura EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Assura's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Assura (LSE:AGR) Business Description

Traded in Other Exchanges
Address
3 Barrington Road, Altrincham, GBR, WA14 1GY
Assura PLC is a healthcare facility REIT. The company operates one segment that develops, owns, and manages primary-care properties. All the company's revenue is generated in the United Kingdom. Assura seeks properties that are characterized by a secure and predictable income stream with an underpinning of inflation linkage. The company considers merger and acquisition investment to be a component of its operational growth strategy. It engages in relationship-building with general practitioners to secure investment opportunities.